Literature DB >> 6300903

pH and the recycling of transferrin during receptor-mediated endocytosis.

A Dautry-Varsat, A Ciechanover, H F Lodish.   

Abstract

At pH 5.4 apotransferrin (iron-free transferrin) binds to cell-surface transferrin receptors to the same extent and with the same affinity as does diferric transferrin at pH 7.0. Apotransferrin is quickly dissociated from its receptor when the pH is raised to 7.0. These and other results strongly support a simple model that explains the cycling of transferrin during a single cycle of receptor-mediated endocytosis. Diferric transferrin binds to cell-surface receptors, and the transferrin-receptor complex is endocytosed. The pH of the endocytic vesicle is lowered to 5.5 or below; this causes dissociation of iron from the transferrin-receptor complex, but apotransferrin remains bound to its receptor. The iron remains within the cell, and the apotransferrin-receptor complex is recycled to the cell surface. Upon encountering the neutral pH of the medium, apotransferrin is dissociated from the cell.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6300903      PMCID: PMC393798          DOI: 10.1073/pnas.80.8.2258

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  The effect of pH upon human transferrin: selective labelling of the two iron-binding sites.

Authors:  A N Lestas
Journal:  Br J Haematol       Date:  1976-03       Impact factor: 6.998

2.  Micropinocytosis of transferrin by developing red cells: an electron-microscopic study utilizing ferritin-conjugated transferrin and ferritin-conjugated antibodies to transferrin.

Authors:  A L Sullivan; J A Grasso; L R Weintraub
Journal:  Blood       Date:  1976-01       Impact factor: 22.113

Review 3.  The low-density lipoprotein pathway and its relation to atherosclerosis.

Authors:  J L Goldstein; M S Brown
Journal:  Annu Rev Biochem       Date:  1977       Impact factor: 23.643

4.  Difference between the two iron-binding sites of transferrin.

Authors:  J V Princiotto; E J Zapolski
Journal:  Nature       Date:  1975-05-01       Impact factor: 49.962

5.  Degradation of receptor-bound human choriogonadotropin by murine Leydig tumor cells.

Authors:  M Ascoli; D Puett
Journal:  J Biol Chem       Date:  1978-07-25       Impact factor: 5.157

6.  Characterization of the low density lipoprotein receptor in membranes prepared from human fibroblasts.

Authors:  S K Basu; J L Goldstein; M S Brown
Journal:  J Biol Chem       Date:  1978-06-10       Impact factor: 5.157

Review 7.  The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins.

Authors:  G Ashwell; A G Morell
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1974

8.  Differences between the binding sites for iron binding and release in human and rat transferrin.

Authors:  E H Morgan; H Huebers; C A Finch
Journal:  Blood       Date:  1978-12       Impact factor: 22.113

9.  Intracellular polypeptide hormone receptors. Characterization of insulin binding sites in Golgi fractions from the liver of female rats.

Authors:  B I Posner; Z Josefsberg; J J Bergeron
Journal:  J Biol Chem       Date:  1978-06-10       Impact factor: 5.157

10.  125I-labeled human epidermal growth factor. Binding, internalization, and degradation in human fibroblasts.

Authors:  G Carpenter; S Cohen
Journal:  J Cell Biol       Date:  1976-10       Impact factor: 10.539

View more
  336 in total

1.  Adenovirus serotype 7 retention in a late endosomal compartment prior to cytosol escape is modulated by fiber protein.

Authors:  N Miyazawa; R G Crystal; P L Leopold
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

2.  A conserved RGD (Arg-Gly-Asp) motif in the transferrin receptor is required for binding to transferrin.

Authors:  V Dubljevic; A Sali; J W Goding
Journal:  Biochem J       Date:  1999-07-01       Impact factor: 3.857

3.  Down-regulation of cell surface receptors is modulated by polar residues within the transmembrane domain.

Authors:  L Zaliauskiene; S Kang; C G Brouillette; J Lebowitz; R B Arani; J F Collawn
Journal:  Mol Biol Cell       Date:  2000-08       Impact factor: 4.138

4.  Multivalent display and receptor-mediated endocytosis of transferrin on virus-like particles.

Authors:  Deboshri Banerjee; Allen P Liu; Neil R Voss; Sandra L Schmid; M G Finn
Journal:  Chembiochem       Date:  2010-06-14       Impact factor: 3.164

5.  Interruption of the cydB locus in Brucella abortus attenuates intracellular survival and virulence in the mouse model of infection.

Authors:  S Endley; D McMurray; T A Ficht
Journal:  J Bacteriol       Date:  2001-04       Impact factor: 3.490

6.  Iron acquisition from transferrin by Candida albicans depends on the reductive pathway.

Authors:  Simon A B Knight; Gaston Vilaire; Emmanuel Lesuisse; Andrew Dancis
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

7.  Differential effects of leupeptin, monensin and colchicine on ligand degradation mediated by the two asialoglycoprotein receptor pathways in isolated rat hepatocytes.

Authors:  B L Clarke; P H Weigel
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

8.  Megalin-dependent cubilin-mediated endocytosis is a major pathway for the apical uptake of transferrin in polarized epithelia.

Authors:  R Kozyraki; J Fyfe; P J Verroust; C Jacobsen; A Dautry-Varsat; J Gburek; T E Willnow; E I Christensen; S K Moestrup
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

9.  Agonist-induced internalization and recycling of the glucagon-like peptide-1 receptor in transfected fibroblasts and in insulinomas.

Authors:  C Widmann; W Dolci; B Thorens
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

10.  Delineation of the endocytic pathway of substance P and its seven-transmembrane domain NK1 receptor.

Authors:  E F Grady; A M Garland; P D Gamp; M Lovett; D G Payan; N W Bunnett
Journal:  Mol Biol Cell       Date:  1995-05       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.